Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

From the Kurma Stable, Step Pharma Convinces a New Fund

Summary by L'AGEFI
Launched by Kurma on the basis of new discoveries by Professor Alain Fischer and Dr Sylvain Latour in immunology, Gessian biotech raises 38 million euros during a C-series tour driven by V-Bio Ventures.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

L'article Biotech Step Pharma raises 38 million euros to refine the targeting of cancer treatment est apparu en premier sur Maddyness - Le média pour comprendre le économie demain.

Read Full Article

Launched by Kurma on the basis of new discoveries by Professor Alain Fischer and Dr Sylvain Latour in immunology, Gessian biotech raises 38 million euros during a C-series tour driven by V-Bio Ventures.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

L'AGEFI broke the news in on Wednesday, October 15, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal